Can Amphetamine Raise VO₂max Yet Fail to Extend Exercise in Heat? Three Rat Experiments

Short answer: In male rats, injected d-amphetamine showed a dose-dependent separation between maximal oxygen uptake, the oxygen cost of running, and the temperature at which exercise ended. A 2 mg/kg dose increased measured maximal oxygen consumption in one crossover experiment, but neither dose made a fixed treadmill workload more economical. In a different experiment at 32 °C, 1 mg/kg prolonged running by about nine minutes while both doses raised the core temperature at exhaustion; 2 mg/kg did not significantly extend running time. These findings concern controlled rodent exercise physiology, not analytically measured amphetamine in a person’s legal venous whole blood, an individual’s athletic safety, or an explanation for a particular death or collision.

The original primary evidence is Zaretsky, Brown, Zaretskaia, Durant, and Rusyniak, The Ergogenic Effect of Amphetamine (2014), Temperature 1(3):242–247, doi:10.4161/23328940.2014.987564. The analysis below separates three physical experiments, retains the saline controls and reported null results, and identifies exactly which biological measurements were obtained.

What is the narrow experimental answer?

The study does not yield a single yes-or-no verdict that amphetamine “improves endurance.” It reports different endpoints in separately designed rat protocols. At approximately room temperature, 2 mg/kg increased maximal oxygen uptake (VO_2max) and delayed reaching that endpoint. The 1 mg/kg regimen delayed reaching it but did not significantly increase its value. When exercise intensity was fixed, oxygen use rose at some workloads after amphetamine: that is evidence against improved economy. In a warm chamber, only the lower dose prolonged the run, whereas both doses led to hotter core readings when the animals stopped.

Thus an apparent capacity to continue exercise can coexist with greater physiological strain. “More oxygen consumed,” “a longer interval until the treadmill protocol ends,” and “a better use of oxygen for a given amount of work” are three different propositions. This is a particularly important distinction when an expert is asked whether stimulant exposure made a person safer, stronger, impaired, or more susceptible to hyperthermia. None of those person-specific questions was tested here.

How many animals were genuinely studied?

The investigators reported an independent 12-rat maximal-oxygen experiment, organized as six animals assigned to the 1 mg/kg dose comparison and six assigned to the 2 mg/kg comparison. Within each assignment, the same rats received saline and their allocated active dose in counterbalanced order on different days. That design produces paired observations, not 24 independently randomized animals. A separate 12-rat cohort was used for running economy, again with six rats per dose comparison and repeated saline/active visits.

For heat-chamber endurance, the protocol comprised 24 rats assigned in parallel to saline, 1 mg/kg, or 2 mg/kg, eight per arm. Each rat underwent the endurance experiment once. The group of eight is the biological unit for that arm: dozens of telemetry readings per rat do not enlarge the independent sample. The paper provides experiment-specific numbers, and they should be retained rather than summing trial episodes, timepoints, and gas-sensor samples as if they were separate subjects.

The animals were adult male Sprague-Dawley rats weighing approximately 300 ± 20 g. Findings in this sex, strain, controlled housing, and treadmill selection procedure do not describe the distribution of effects in female rats, children, adult drivers, human athletes, or patients with coexisting diseases.

Which chemical was given, and how?

The investigators administered d-amphetamine obtained for laboratory use and diluted in sterile 0.9% saline to an injection volume of 1 mL/kg. Assigned active doses were 1 or 2 mg per kilogram of the animal’s body weight, given intraperitoneally. Saline served as the control. This is not a study of methamphetamine, oral lisdexamfetamine, extended-release stimulants, or intravenous human exposure. Although drugs in these families can have overlapping pharmacology, their chemical identity, conversion, route of administration, and concentration–time curves are not interchangeable.

A nominal injected dose is an intervention specified by the experimenter. It does not itself represent a measured drug concentration in blood, plasma, serum, brain, or another specimen. In this paper the researchers reported gas-exchange and temperature measurements, but did not present a postdose bioanalytical amphetamine concentration series. No validated blood-to-effect or dose-to-blood conversion can therefore be recovered from these results.

How were maximal oxygen uptake and exhaustion determined?

For the maximal oxygen trial, animals were familiarized to a motorized treadmill before testing. An open-circuit indirect-calorimetry apparatus, Oxymax, analyzed gases in an enclosed running chamber. The researchers calibrated its gas analyzers with standard mixtures and obtained resting readings after a stabilization period. Oxygen uptake was recorded every 30 seconds and expressed relative to body weight. The treadmill protocol increased speed and incline in three-minute stages, initially 10 m/min on level ground, followed by 10 m/min at a 5° incline and further increments of 5 m/min and 5°.

The test ended if uptake plateaued despite increased workload or the rat could no longer stay on the moving belt and experienced three consecutive stimuli without resuming running. The highest recorded oxygen consumption was termed VO_2max. That definition depends on the laboratory’s staged protocol and termination rule; it is not equivalent to a clinical cardiopulmonary stress test in a human or a direct assay of cellular oxygen delivery. Saline and active-dose visits were separated by at least two days, with injection sequence counterbalanced to limit order effects.

What did the 1 and 2 mg/kg oxygen trials establish?

The lower-dose animals took an additional reported 1.7 ± 0.5 minutes to attain the maximal-uptake stopping point on amphetamine compared with saline (reported p = .03), without a significant difference in maximal oxygen consumption. For the higher-dose animals, maximal uptake increased by 861 ± 184 mL/kg/hour compared with saline (p = .005), and the time to that endpoint increased by 2.5 ± 0.8 minutes (p = .03). Those are paired, dose-specific comparisons, not a prespecified direct superiority test of 2 mg/kg over 1 mg/kg.

Results do not imply that every animal improved, that the same changes would occur under constant-speed work, or that higher uptake is necessarily desirable. The source presented the changes with standard errors and conventional significance tests. It did not supply individual raw physiological records in the material reviewed, so person-style classifications, exact prediction intervals, and threshold probabilities must not be reconstructed from mean differences alone.

Why is running economy not the same as VO₂max?

Running economy asks how much oxygen the animal consumes at a specified external workload. In a different crossover cohort, rats completed six-minute steady-state periods at approximately 10 m/min level, 15 m/min at 10°, and 18 m/min at 15°, intended to approximate 70%, 80%, and 90% of the earlier maximal workload. Oxygen use at the same belt setting is the relevant comparison. A higher oxygen requirement at an unchanged workload signals a higher metabolic cost—not an improvement in economy.

Neither dose materially changed resting or approximately 70% workload oxygen consumption in the source comparisons. At the roughly 80% workload, the 1 mg/kg group showed an increase, and the 2 mg/kg group was described as trending toward an increase. At approximately 90%, the higher-dose cohort consumed more oxygen; the lower-dose cohort did not show that difference. The paper does not print separate exact p-values for every plotted workload contrast in its XML narrative. It would be incorrect to invent those values or convert a stated trend into a proven effect.

This matters because a reader may equate “larger maximum oxygen uptake” with greater efficiency. In fact the two findings can coexist: a stimulant may alter the measured aerobic ceiling while increasing metabolic expenditure for a given task. The experiment did not directly measure skeletal-muscle ATP efficiency, mitochondrial coupling, or the relative contributions of locomotion and non-work thermogenesis.

What happened in the 32 °C heat experiment?

A third protocol used an environmental chamber held at approximately 32 ± 1 °C with low humidity, rather than the approximately 25 °C room-temperature conditions used in the earlier oxygen tests. Rats ran at a fixed speed of 18 m/min and a 5° incline after one assigned saline or active intraperitoneal injection. The investigators used implanted intraperitoneal transmitters to monitor core temperature minute by minute and defined exhaustion by three consecutive failure-to-resume treadmill stimuli. The investigator conducting the tests was blinded to assigned treatment.

Compared with saline, the 1 mg/kg group ran about 9.4 minutes longer before exhaustion (p = .02). The 2 mg/kg group was described as reaching exhaustion at a time comparable with saline, not as having the same statistically significant endurance benefit. Yet both active-dose groups were hotter when they stopped: the source gave about 41.6 ± 0.3 °C after saline, 42.0 ± 0.2 °C after 1 mg/kg, and 42.1 ± 0.2 °C after 2 mg/kg, presented as means ± standard errors. The smaller 1 mg/kg temperature difference was reported with p = .01; the 2 mg/kg temperature comparison with p = .003.

The repeated temperature observations establish a time course within each rat, but they are not independent animals or a human heat-stroke diagnostic series. Higher core temperature at task termination is a physiological observation. It does not by itself establish tissue injury, histological heat damage, an individual lethal threshold, or the cause of any real-world death.

Quantitative evidence: dose, protocol, and tested outcome

The source used paired testing for the room-temperature crossover outcomes. All ± values shown for changes are reported standard errors, not ranges for individual animals. Gas exchange was measured from the treadmill respiratory system, not from chemically quantified amphetamine in blood.

Quantitative evidence: time and temperature in the heat

These are separate parallel treatment arms; measurements every minute do not convert eight rats into hundreds of independent experimental units. The paper did not establish a statistical equality between high-dose and saline endurance, only that an additional endurance advantage was not demonstrated in its reported test.

Which endpoints were truly significant, nonsignificant, or absent?

The reported statistically significant findings include the lower-dose delay in reaching maximal oxygen uptake, higher-dose increases in both its magnitude and timing, the lower-dose endurance extension in warmth, and the higher stopping temperature in each active heat-chamber group. The primary genuine nonsignificant comparisons are equally important: 1 mg/kg did not significantly elevate VO₂max; baseline and low-workload economy tests did not show a drug effect; the 2 mg/kg heat group did not show a significant longer run; and the researchers did not demonstrate a universal improvement in oxygen economy. These are distinct hypotheses and are not mutually exclusive.

Other things were never measured. The original experiments did not collect a time series of amphetamine concentrations, directly quantify norepinephrine or dopamine in brain, measure creatine kinase or histologic muscle injury, record actual human perceptions of fatigue, or compare two amphetamine blood specimens. The absence of a study measurement is not a nonsignificant test result. Likewise, an absent exact p-value should remain absent rather than being imputed from the appearance of a figure caption.

Many small comparisons and workload analyses were conducted with conventional hypothesis testing, including least-significant-difference post hoc procedures for some groups. Without adjustment or replication, a nominal threshold crossing in a six- or eight-rat group warrants narrower language than “proved the effect.”

Why could oxygen consumption rise without safer endurance?

Maximal oxygen uptake describes the highest system-level gas-exchange rate reached under a defined challenge. It is not necessarily a direct measure of efficient muscular work. Amphetamine can affect thermoregulation, arousal, locomotion, vasomotor tone, and other processes. The authors proposed that additional non-work oxygen consumption or heat generation might help explain why the maximal measure rose while fixed-workload economy did not improve. In their experiment, however, the oxygen apparatus measured whole-animal gas exchange; it did not separate muscle and brown-adipose oxygen consumption.

At a warm ambient temperature, a longer run also creates additional exposure time to heat stress. The lower-dose group both continued longer and ended hotter. The high-dose group ended hotter without a comparably demonstrated increase in running duration. That pattern is consistent with a boundary on the apparent ergogenic advantage, but it cannot uniquely identify one mechanism. Central masking of fatigue, thermogenesis, and cardiovascular redistribution remain hypotheses unless directly separated by further intervention and measurement.

What did the instruments actually measure?

The respiratory apparatus estimated oxygen uptake from gas exchange through a calibrated open-circuit system. Treadmill speed, incline, and termination rules were directly controlled laboratory variables. Implanted abdominal telemetry measured core body temperature in the warmed-environment protocol. Those are legitimate physical and physiological measurements, but they address energy expenditure and heat balance rather than the identity and amount of a drug in a clinical specimen.

No headspace gas result is a breath-amphetamine concentration; exhaled gas for respirometry is not the same analytical target as a validated breath drug test. No oxygen uptake in mL/kg/hour can be converted into amphetamine ng/mL in a legal human blood tube. Any interpretation must first identify the original target analyte, matrix, instrument and measured unit. Here the administered molecule was specified, while quantitative parent-drug exposure within biological fluids was not assayed.

Why the forensic specimen distinction is decisive

Legal venous whole blood is not the same specimen as plasma or serum separated by centrifugation. Urine screening, oral fluid, hair, sweat, vitreous humor, exhaled breath, artificial solutions and animal tissue each answer different analytical questions. In this article’s original source, none of these matrices contains a published quantitative postdose amphetamine determination. There is therefore no observed blood concentration to compare with a case result, no extraction or chromatographic method for amphetamine to audit, and no analytical detection limit or quantitation limit to report.

The distinction also applies to dose. A rat receiving an intraperitoneal mass per kilogram cannot be placed onto a human oral dosing curve without species-appropriate absorption, elimination, distribution, and pharmacodynamic information. Even a measured blood concentration would require specimen-timed contextual interpretation before relating it to a person’s behavior; an unmeasured concentration provides still less basis for such an inference. For specimen-specific principles, see the site’s published guide to biological matrices and its separately verified explanation of confirmatory drug testing.

Could this study determine an athlete’s or a driver’s impairment?

No. A treadmill rat does not undergo on-road hazard detection, lane keeping, balance assessment, standardized field sobriety testing, speed choice, eyewitness recall, or a workplace safety simulation. The animals were selected for their ability to run reliably in a motorized apparatus; they were not randomly sampled from human occupational populations. Neither the injection route nor the environmental protocol reproduces the pharmacokinetics of typical human amphetamine use.

A real impairment inquiry would require individual case measurements and evidence relevant to the activity at issue, including timing, the actual specimen, analytical validation, observed driving or workplace behavior, alternative causes, co-exposures, medical state, and the appropriate governing standard. One cannot use the article’s higher rat core temperature to decide that a particular person was intoxicated, reckless, criminally aggressive, credible or not credible, or the cause of a collision. A physiological risk hypothesis does not establish a legal fact about an event.

Does the study prove a heatstroke threshold?

No universal threshold follows from these observations. The heat rats had group-average core temperatures near 42 °C when they stopped, but their endpoint was a treadmill recovery rule, not a medically confirmed heatstroke diagnosis. The article did not report autopsy findings, organ injury biomarkers, or survival analyses that would connect these numerical values to irreversible heat injury. The environment was warm and relatively dry, the animals were laboratory-acclimated males, and the exercise demand was fixed by the apparatus.

The result may inform a mechanistic discussion of heat strain and a possible mismatch between perceived capacity and physiological burden. It cannot supply a standalone cutoff for death, injury, clinical intervention, or the causation of a particular athletic collapse. Differences between rats and humans in body surface area, thermoregulation, training, hydration and drug disposition remain material.

How should a scientific report use these results?

A defensible report should first state the exact compound, animal preparation, injection route, room versus warm conditions, the number of independent rats, and whether each comparison was paired or parallel. It should then present the measured endpoint, original mean difference or group mean, uncertainty as reported, and both significant and nonsignificant observations. The physiological interpretation should be explicitly distinguished from the direct measurement.

If the case concerns chemical toxicology, the report must separately evaluate the original case specimen and laboratory method. Findings about animal oxygen use should not become a surrogate for human parent-amphetamine concentration. Likewise, the authors’ suggested central fatigue masking should not be rewritten as a directly measured dopamine mechanism. Competing causes of heat illness, seizure, intoxication, fatigue, impaired judgment, or occupational failure would require their own records and tests.

One of the paper’s strengths is that it examined three conceptually different endpoints rather than using “performance” as an undifferentiated label. Its principal boundaries are small experiment-specific rat groups, absence of drug bioanalysis, the selected treadmill endpoint, and incomplete identification of the physiological mechanism. Those limits do not negate the reported experiment; they define what it can responsibly support.

Frequently asked questions

1. Did a higher dose automatically produce a longer run?

No. The 2 mg/kg group had higher maximal oxygen uptake in its room-temperature protocol, but in the 32 °C parallel experiment it did not show the lower dose’s significant endurance extension. Protocol and environment matter.

2. Were 48 oxygen-trial observations made on independent animals?

No. Each of the two room-temperature protocols assigned six rats per dose subgroup and retested each rat on saline and active drug. The 24 warm-chamber rats were in three parallel groups. Count rats within the stated experiment, not gas readings or visits.

3. Was amphetamine measured in human venous whole blood?

No. This was an animal physiology paper without a published quantitative postdose amphetamine assay in human venous whole blood or any other forensic drug matrix. It cannot yield a human ng/mL result or last-use estimate.

4. Does more VO₂max mean better running economy?

No. Maximal uptake increased after 2 mg/kg, yet oxygen consumption at a given fixed workload was not reduced and was sometimes higher. Economy and maximal capacity are distinct dependent variables.

5. Did every temperature comparison reach statistical significance?

The source reported significant higher temperatures at exhaustion for both active heat groups relative to saline (1 mg/kg p=.01; 2 mg/kg p=.003). It did not report a significant endurance-time advantage for 2 mg/kg or an exact null p-value for that contrast.

6. Was heatstroke or muscle injury diagnosed?

No. Abdominal telemetry recorded core temperature during forced treadmill work. The original experiment did not include a clinical heatstroke diagnostic endpoint, histologic injury evaluation, or human injury data.

7. Can an expert use this paper to prove impairment or accident causation?

Not on its own. It supplies rat experimental evidence about gas exchange, exercise duration and core heat, not an individual human biological drug measurement, on-road task, eyewitness reliability test, or reconstruction of a particular event.

Bottom line

In this original rat research, a 2 mg/kg intraperitoneal d-amphetamine dose raised measured maximum oxygen uptake while the oxygen economy of fixed treadmill exercise did not improve. Under warm conditions both administered doses increased the temperature at which exercise ended, but only 1 mg/kg clearly lengthened time to exhaustion. Those experimental outcomes support a dose- and environment-dependent distinction between apparent endurance and heat burden, not a universal improvement in performance or a forensic drug-concentration rule.

The original investigation is Zaretsky and colleagues, The Ergogenic Effect of Amphetamine, DOI 10.4161/23328940.2014.987564. A real case requires its own properly identified biological specimen, analytical record and event-specific evidence before any conclusion about a particular human.